NICHD Maternal Fetal Medicine Units Network

NICHD 母胎医学单位网络

基本信息

  • 批准号:
    9891074
  • 负责人:
  • 金额:
    $ 26.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1992
  • 资助国家:
    美国
  • 起止时间:
    1992-04-08 至 2021-03-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): This proposal is the application of The Ohio State University (OSU) for continued participation in the NICHD Maternal Fetal Medicine Units (MFMU) Network. The current application describes our team, environment and resources to meet the objectives of the Network. Our newly energized team has a strong commitment to continue and expand our high level of performance in the Network since 1992. We have a strong experience in conducting clinical and translational research. Dr. Catalin Buhimschi was recruited to the OSU Wexner Medical Center in 2013. As Ohio State's Alternate Principal Investigator (PI) since 2014, he assumed local leadership, energized our research team, worked closely with Network's Publication Committee, and co-authored a concept presentation to the Steering Committee. The final cumulative performance report lists OSU as 1st in recruitment for HCV, 4th in ALPS, 6th in CMV trials, and 3rd - 4th best for overall recruitment. In the current application Dr. Buhimschi will serve as PI and work with Dr. Mark Landon, an established Network investigator, as Alternate PI. The OSU Network will recruit study participants from diverse populations at 3 medical centers with a combined total of more than 15,000 annual births. We have a large group of faculty & research staff capable of recruiting patients in the setting of an excellent research organization enhanced by 24 years of experience in the MFMU, participation in the NICHD Nulliparous Network, and memberships in the North American Fetal Treatment Network, and Ohio Perinatal Research Network (OPRN) - a large regional perinatal research repository with a state-of-the-art data collection system. We benefit from a robust bioinformatics structure, an extraordinary group of obstetrical sonographers, perinatal epidemiologists, and a mature research infrastructure supported by a CTSA grant shared with Nationwide Children's Hospital. Our satellite, Miami Valley Hospital in Dayton has an outstanding record of recruitment in the most recent Network cycle, 2011- 2016. Good Samaritan Hospital, the largest maternity service in Ohio, has worked closely with OSU faculty in statewide projects, has a well-established research culture and an ambitious agenda for MFMU Network participation. Our relationship with Nationwide Children's Hospital in clinical care and research has never been stronger, and includes a unique symbiosis with Center for Perinatal Research. We look forward to continuing our tradition of service and innovation in the next cycle of the NICHD MFMU Network. Our goal is to continue to be leaders in protocol development, recruitment, start-up and completion, data analysis, manuscript publication in top journals and support to the Network's tasks across all research protocols and centers.
 描述(由应用程序提供):该提案是俄亥俄州立大学(OSU)继续参与NICHD母体胎儿医学单位(MFMU)网络的应用。当前的应用程序描述了我们的团队,环境和资源以满足网络的目标。自1992年以来,我们新充满活力的团队致力于继续和扩大我们在网络中的高度绩效。我们在进行临床和翻译研究方面拥有丰富的经验。卡塔林·布希姆斯(Catalin Buhimschi)博士于2013年被招募到OSU Wexner医疗中心。作为俄亥俄州立大学的替代首席研究员(PI),他担任当地领导层,使我们的研究团队充满活力,并与Network的出版物委员会密切合作,并为指导委员会合作。最终的累积性能报告将OSU列为HCV招聘的第一名,阿尔卑斯山第四名,CMV试验中的第六名,总体招募第三名。在当前的应用程序中,Buhimschi博士将担任PI,并与已建立的网络调查员Mark Landon博士一起担任替代PI。 OSU网络将招募来自3个医疗中心的潜水员人群的研究参与者,总计超过15,000个年龄。 We have a large group of faculty & research staff Capable of recruiting patients in the setting of an excellent research organization enhanced by 24 years of experience in the MFMU, participation in the NICHD Nulliparous Network, and memberships in the North American Fetal Treatment Network, and Ohio Perinatal Research Network (OPRN) - a large regional perinatal research repository with a state-of-the-art data collection system.我们从强大的生物信息学结构中受益,这是一群非凡的妇产科医师,围产期流行病学家,以及由与全国儿童医院共享的CTSA赠款支持的成熟研究基础设施。我们位于代顿的卫星迈阿密山谷医院在2011年至2016年的最新网络周期中招募了杰出的记录。俄亥俄州最大的孕妇服务公司Good Samaritan医院在全州项目中与OSU教职员工密切合作,拥有良好的研究文化,并为MFMU网络参与而有一个雄心勃勃的Agernda。我们与全国儿童医院在临床护理和研究方面的关系从未如此牢固,其中包括一个独特的符号,并具有围产期研究中心。我们期待在NICHD MFMU网络的下一个周期中继续我们的服务和创新传统。我们的目标是继续成为协议开发,招聘,启动和完成的领导者,数据分析,顶级期刊中的手稿出版以及对所有研究协议和中心中网络任务的支持。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Maged Costantine其他文献

Maged Costantine的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Maged Costantine', 18)}}的其他基金

Developing Extracellular Vesicle Based MPRINT Translational Resource Platform for Monitoring Therapeutics Response During Pregnancy
开发基于细胞外囊泡的 MPRINT 转化资源平台,用于监测妊娠期间的治疗反应
  • 批准号:
    10747545
  • 财政年份:
    2023
  • 资助金额:
    $ 26.62万
  • 项目类别:
1/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk women
1/2 普伐他汀预防高危女性先兆子痫的随机对照试验
  • 批准号:
    10087196
  • 财政年份:
    2019
  • 资助金额:
    $ 26.62万
  • 项目类别:
1/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk women
1/2 普伐他汀预防高危女性先兆子痫的随机对照试验
  • 批准号:
    10705607
  • 财政年份:
    2019
  • 资助金额:
    $ 26.62万
  • 项目类别:
1/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk women
1/2 普伐他汀预防高危女性先兆子痫的随机对照试验
  • 批准号:
    10162643
  • 财政年份:
    2019
  • 资助金额:
    $ 26.62万
  • 项目类别:
1/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk women
1/2 普伐他汀预防高危女性先兆子痫的随机对照试验
  • 批准号:
    10455106
  • 财政年份:
    2019
  • 资助金额:
    $ 26.62万
  • 项目类别:
NICHD maternal fetal medicine units network
NICHD母胎医学单位网
  • 批准号:
    10681772
  • 财政年份:
    1992
  • 资助金额:
    $ 26.62万
  • 项目类别:
NICHD maternal fetal medicine units network
NICHD母胎医学单位网
  • 批准号:
    10379413
  • 财政年份:
    1992
  • 资助金额:
    $ 26.62万
  • 项目类别:
NICHD maternal fetal medicine units network
NICHD母胎医学单位网
  • 批准号:
    10254471
  • 财政年份:
    1992
  • 资助金额:
    $ 26.62万
  • 项目类别:
Comprehensive evaluation of the safety and utility of pravastatin in prevention of preeclampsia in high-risk pregnant women
普伐他汀预防高危孕妇子痫前期的安全性和有效性综合评价
  • 批准号:
    9119186
  • 财政年份:
  • 资助金额:
    $ 26.62万
  • 项目类别:

相似海外基金

Dietary prevention for colorectal cancer: targeting the bile acid/gut microbiome axis
结直肠癌的饮食预防:针对胆汁酸/肠道微生物组轴
  • 批准号:
    10723195
  • 财政年份:
    2023
  • 资助金额:
    $ 26.62万
  • 项目类别:
Effects of Dietary Patterns and Sodium Intake on the Gut Microbiome and Metabolome
饮食模式和钠摄入量对肠道微生物组和代谢组的影响
  • 批准号:
    10888821
  • 财政年份:
    2023
  • 资助金额:
    $ 26.62万
  • 项目类别:
Phase I study of panobinostat in adults with sickle cell disease: novel approach to recruitment and retention
帕比司他治疗成人镰状细胞病的 I 期研究:招募和保留的新方法
  • 批准号:
    10420453
  • 财政年份:
    2023
  • 资助金额:
    $ 26.62万
  • 项目类别:
Prenatal stress and diet, and the fetal epigenome
产前压力和饮食,以及胎儿表观基因组
  • 批准号:
    10523353
  • 财政年份:
    2022
  • 资助金额:
    $ 26.62万
  • 项目类别:
Informatics-Based Digital Application to Promote Safe Exercise in Middle-Aged Adults with Type 1 Diabetes
基于信息学的数字应用促进中年 1 型糖尿病患者的安全运动
  • 批准号:
    10887767
  • 财政年份:
    2022
  • 资助金额:
    $ 26.62万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了